ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 174 filers reported holding ACORDA THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 2.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $42,000 | -54.3% | 45,516 | 0.0% | 0.00% | – |
Q4 2019 | $92,000 | -76.0% | 45,516 | -9.3% | 0.00% | -100.0% |
Q2 2019 | $383,000 | -42.6% | 50,160 | 0.0% | 0.00% | -50.0% |
Q1 2019 | $667,000 | -7.5% | 50,160 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $721,000 | -26.7% | 50,160 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $983,000 | -43.0% | 50,160 | -16.6% | 0.00% | -50.0% |
Q2 2018 | $1,724,000 | +21.7% | 60,160 | 0.0% | 0.00% | +33.3% |
Q1 2018 | $1,417,000 | +9.8% | 60,160 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $1,290,000 | -11.9% | 60,160 | -4.3% | 0.00% | -25.0% |
Q3 2017 | $1,464,000 | +9.1% | 62,860 | -8.0% | 0.00% | 0.0% |
Q2 2017 | $1,342,000 | -2.3% | 68,309 | +4.1% | 0.00% | 0.0% |
Q1 2017 | $1,374,000 | +22.7% | 65,609 | +10.2% | 0.00% | +33.3% |
Q4 2016 | $1,120,000 | -56.5% | 59,562 | -51.7% | 0.00% | -25.0% |
Q3 2016 | $2,576,000 | +70.8% | 123,402 | +108.6% | 0.00% | -20.0% |
Q2 2016 | $1,508,000 | +1126.0% | 59,160 | +1173.9% | 0.01% | – |
Q1 2016 | $123,000 | -38.2% | 4,644 | 0.0% | 0.00% | -100.0% |
Q4 2015 | $199,000 | +61.8% | 4,644 | 0.0% | 0.00% | – |
Q3 2015 | $123,000 | -20.1% | 4,644 | 0.0% | 0.00% | -100.0% |
Q2 2015 | $154,000 | 0.0% | 4,644 | 0.0% | 0.00% | 0.0% |
Q1 2015 | $154,000 | -18.5% | 4,644 | 0.0% | 0.00% | 0.0% |
Q4 2014 | $189,000 | +19.6% | 4,644 | 0.0% | 0.00% | 0.0% |
Q3 2014 | $158,000 | +167.8% | 4,644 | +166.6% | 0.00% | – |
Q2 2014 | $59,000 | -10.6% | 1,742 | 0.0% | 0.00% | – |
Q1 2014 | $66,000 | +29.4% | 1,742 | 0.0% | 0.00% | – |
Q4 2013 | $51,000 | – | 1,742 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|